Dear Colleagues,
The 2020 Virtual Introductory Training Course on
'Pharmacokinetics and Pharmacodynamics of Protein Therapeutics - Principles & Pharmacometric Approaches'
will be held on December 4-6, 2020.
The 3-day course continues on the successful concept used in previous year offerings. It will introduce participants to basic principles in the pharmacokinetic and pharmacodynamic evaluation of novel therapeutic proteins and will provide PK and PK/PD modeling and simulation examples relevant to therapeutic proteins. Topics include target-mediated drug disposition, interspecies scaling, first-in human dose selection, model-informed drug development, pediatric pharmacology, drug-drug interactions, and immunogenicity. The target audience comprises pharmaceutical scientists from industry, academia and regulatory agencies with basic knowledge in PK and PKPD that had only limited exposure to the challenges associated with developing therapeutic proteins and that would like to receive a comprehensive overview or refresher on the PK and PKPD of this class of compounds.
Although the course includes some hands-on exercises, participants do NOT need to have prior experience with any particular PKPD analysis software.
For more detailed information on the preliminary course program and timing, as well as on the registration process, please visit
http://www.PKPDofProteinTherapeutics.com
We hope you will join us in December!
The Course Directors
Bernd Meibohm & Johan Gabrielsson
Bernd Meibohm, PhD, FCP, FAAPS
Associate Dean for Research & Graduate Programs
Professor of Pharmaceutical Sciences
The University of Tennessee Health Science Center
College of Pharmacy
Pharmacy Building, Suite 435
881 Madison Avenue
Memphis, TN 38163, USA
bmeibohm
t: +1.901.448.1206
f: +1.901.448.6940